Prevalence and factors associated with liver fibrosis among first‐degree relatives of Mexican Americans with hepatocellular carcinoma
Alimentary Pharmacology & Therapeutics · 2023
DOI: 10.1111/apt.17384 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2023. Verfasst von Suzanne Sharpton und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Non-alcoholic Fatty Liver Disease, Liver Neoplasms, Elasticity Imaging Techniques. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIEHS NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Background and Aims Whether hepatocellular carcinoma (HCC) increases the familial risk for hepatic fibrosis has not been thoroughly explored, particularly in Mexican Americans who are disproportionately affected by obesity and metabolic syndrome. We evaluated the risk of significant hepatic fibrosis in first‐degree relatives of Mexican American adults with HCC.
Methods
We performed a cross‐sectional analysis of a prospective cohort of Mexican American probands with HCC and first‐degree relatives enrolled in the Hispanic Liver Cancer Cohort study. We evaluated the prevalence of hepatic fibrosis in first‐degree relatives, defined by liver stiffness measurement (LSM) >= 7.0 kPa with transient elastography (TE). Secondary outcomes included the prevalence of definite hepatic steatosis, defined by controlled attenuation parameter >=288 dB/m.
Results
We identified 70 probands diagnosed with HCC; 47% were female and the mean age was 62 years (±13 years). Among 112 first‐degree relatives with a mean age of 43 years (±14 years), 19 (17%) had significant fibrosis and 47 (42%) had definite hepatic steatosis, respectively. The prevalence of significant fibrosis was 20% in first‐degree relatives 40 years of age or older. Regression analysis revealed that diabetes (OR 3.2, 95% CI: 1.1–9.2, p = 0.03) and aspartate aminotransferase >=30 units/L (OR 4.0, 95% CI: 1.4–11.7, p = 0.01) were predictors of significant fibrosis in first‐degree relatives.
Conclusions
Using a well‐phenotyped familial cohort, we found that the prevalence of significant fibrosis and definite hepatic steatosis are high in first‐degree relatives of Mexican Americans with HCC, particularly those with diabetes, suggesting that this population may benefit from screening for liver disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Medicine, NAFLD Research Center, University of California, San Diego, La Jolla, California, USA.
- Department of Epidemiology, Genetics and Environmental Sciences, University of Texas School of Public Health, Brownsville, Texas, USA.
- Division of Gastroenterology, University of California, San Diego, La Jolla, California, USA.
- Department of Family Medicine and Public Health, Division of Epidemiology, University of California, San Diego, La Jolla, California, USA.
ORCID-Profile: Rohit Loomba
Förderung
- NCATS NIH HHS
- NIEHS NIH HHS
- NIDDK NIH HHS
- NIAAA NIH HHS
- NHLBI NIH HHS
- Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston
- National Center for Advancing Translational Sciences
- National Institute of Environmental Health Sciences
Zitieren
APA
Sharpton, S., Shan, K., Bettencourt, R., Lee, M., McCormick, J. B., Fisher-Hoch, S. P., & Loomba, R. (2023). Prevalence and factors associated with liver fibrosis among first‐degree relatives of Mexican Americans with hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17384
Vancouver
Sharpton S, Shan K, Bettencourt R, Lee M, McCormick JB, Fisher-Hoch SP, et al. Prevalence and factors associated with liver fibrosis among first‐degree relatives of Mexican Americans with hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics. 2023. doi:10.1111/apt.17384
BibTeX
@article{Sharpton2023,
author = {Sharpton, Suzanne and Shan, Kuangda and Bettencourt, Ricki and Lee, Miryoung and McCormick, Joseph B and Fisher-Hoch, Susan P and Loomba, Rohit},
title = {Prevalence and factors associated with liver fibrosis among first‐degree relatives of Mexican Americans with hepatocellular carcinoma},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2023},
doi = {10.1111/apt.17384}
}
EUVIMED